Designing smart polymer conjugates for controlled release of payloads

F Seidi, R Jenjob, D Crespy - Chemical reviews, 2018 - ACS Publications
Incorporating labile bonds inside polymer backbone and side chains yields interesting
polymer materials that are responsive to change of environmental stimuli. Drugs can be …

Glycosaminoglycan‐based biohybrid hydrogels: a sweet and smart choice for multifunctional biomaterials

U Freudenberg, Y Liang, KL Kiick… - Advanced …, 2016 - Wiley Online Library
Glycosaminoglycans (GAGs) govern important functional characteristics of the extracellular
matrix (ECM) in living tissues. Incorporation of GAGs into biomaterials opens up new routes …

Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice

N Lohmann, L Schirmer, P Atallah, E Wandel… - Science translational …, 2017 - science.org
Excessive production of inflammatory chemokines can cause chronic inflammation and thus
impair cutaneous wound healing. Capturing chemokine signals using wound dressing …

Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry

LT Jae, M Raaben, M Riemersma, E Van Beusekom… - Science, 2013 - science.org
Glycosylated α-dystroglycan (α-DG) serves as cellular entry receptor for multiple pathogens,
and defects in its glycosylation cause hereditary Walker-Warburg syndrome (WWS). At least …

[HTML][HTML] Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices

D Hachim, TE Whittaker, H Kim, MM Stevens - Journal of Controlled …, 2019 - Elsevier
Controlled, localized drug delivery is a long-standing goal of medical research, realization of
which could reduce the harmful side-effects of drugs and allow more effective treatment of …

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

I Vlodavsky, N Ilan, A Naggi… - Current pharmaceutical …, 2007 - ingentaconnect.com
Heparanase is an endoglycosidase which cleaves heparan sulfate (HS) and hence
participates in degradation and remodeling of the extracellular matrix (ECM). Heparanase is …

Saccharides, oligosaccharides, and polysaccharides nanoparticles for biomedical applications

F Seidi, R Jenjob, T Phakkeeree, D Crespy - Journal of controlled release, 2018 - Elsevier
Modern requirements for designing efficient nanocarriers against diseases such as cancer
are very complex. A suitable nanocarrier should indeed remain colloidally stable in the …

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Non-anticoagulant heparins and inhibition of cancer

B Casu, I Vlodavsky, RD Sanderson - Pathophysiology of haemostasis …, 2007 - karger.com
Low-molecular-weight heparins (LMWH) appear to prolong survival of patients with cancer.
Such a beneficial effect is thought to be associated with interruption of molecular …

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

B Casu, A Naggi, G Torri - Matrix biology, 2010 - Elsevier
The heparan sulfate (HS) chains of heparan sulfate proteoglycans (HSPG) are “ubiquitous”
components of the cell surface and the extracellular matrix (EC) and play important roles in …